These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8056023)

  • 1. Significance of ureteral carcinoma in situ in specimens of cystectomy.
    Batista JE; Palou J; Iglesias J; Sanchotene E; da Luz P; Algaba F; Villavicencio H
    Eur Urol; 1994; 25(4):313-5. PubMed ID: 8056023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ureteral carcinoma in situ at radical cystectomy: does the margin matter?
    Silver DA; Stroumbakis N; Russo P; Fair WR; Herr HW
    J Urol; 1997 Sep; 158(3 Pt 1):768-71. PubMed ID: 9258077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes.
    Moschini M; Shariat SF; Abufaraj M; Soria F; Klatte T; Croce G; Mattei A; Damiano R; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
    Urol Oncol; 2017 Apr; 35(4):151.e17-151.e23. PubMed ID: 27932269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Concomitant Carcinoma In Situ in the Radical Cystectomy Specimen: A Systematic Review and Meta-Analysis.
    Kimura S; Mari A; Foerster B; Abufaraj M; Vartolomei MD; Stangl-Kremser J; Karakiewicz PI; Egawa S; Shariat SF
    J Urol; 2019 Jan; 201(1):46-53. PubMed ID: 30077559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological Behavior and Long-Term Outcomes of Carcinoma In Situ in Upper Urinary Tract Managed by Radical Nephroureterectomy.
    Inamoto T; Matsuyama H; Ibuki N; Komura K; Takahara K; Fujimoto K; Shiina H; Sakano S; Nagao K; Miyake M; Tatsumi Y; Yasumoto H; Azuma H;
    J Urol; 2018 Apr; 199(4):933-939. PubMed ID: 29037861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of cancer involvement at the ureteral margin detected on routine frozen section analysis during radical cystectomy.
    Lee SE; Byun SS; Hong SK; Chang IH; Kim YJ; Gill MC; Song SH; Kim KT
    Urol Int; 2006; 77(1):13-7. PubMed ID: 16825809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and pathologic characteristics of small cell neuroendocrine carcinoma of urinary tract].
    Guo AT; Chen W; Wei LX
    Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):747-51. PubMed ID: 23302335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frozen section analysis of ureteral margins in patients undergoing radical cystectomy for bladder cancer: differential impact of carcinoma in situ in the bladder on reliability and impact on tumour recurrence in the upper urinary tract.
    Loeser A; Katzenberger T; Vergho DC; Kocot A; Burger M; Riedmiller H
    Urol Int; 2014; 92(1):50-4. PubMed ID: 24192612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent predictors for bladder outcomes after treatment of intravesical recurrence following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma.
    Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Hagiwara M; Kosaka T; Oyama M; Miyajima A; Momma T; Nakagawa K; Jinzaki M; Hasegawa S; Nakajima Y; Oya M
    Ann Surg Oncol; 2014 Sep; 21(9):3151-8. PubMed ID: 24682698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
    Tilki D; Reich O; Svatek RS; Karakiewicz PI; Kassouf W; Novara G; Ficarra V; Chade DC; Fritsche HM; Gerwens N; Izawa JI; Lerner SP; Schoenberg M; Stief CG; Skinner E; Lotan Y; Sagalowsky AI; Shariat SF
    J Urol; 2010 May; 183(5):1757-63. PubMed ID: 20299059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
    Rink M; Ehdaie B; Cha EK; Green DA; Karakiewicz PI; Babjuk M; Margulis V; Raman JD; Svatek RS; Fajkovic H; Lee RK; Novara G; Hansen J; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Fisch M; Scherr DS; Shariat SF; ;
    Eur Urol; 2012 Oct; 62(4):677-84. PubMed ID: 22349570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upper urinary tract recurrence after radical cystectomy for bladder cancer: incidence and risk factors.
    Takayanagi A; Masumori N; Takahashi A; Takagi Y; Tsukamoto T
    Int J Urol; 2012 Mar; 19(3):229-33. PubMed ID: 22121922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French study.
    Pignot G; Salomon L; Neuzillet Y; Masson-Lecomte A; Lebacle C; Patard JJ; Lunardi P; Rischmann P; Pasticier G; Bernhard JC; Cohen J; Timsit MO; Verkarre V; Peyronnet B; Verhoest G; Le Goux C; Zerbib M; Brecheteau F; Bigot P; Larre S; Murez T; Thuret R; Lacarriere E; Champy C; Roupret M; Comperat E; Berger J; Descazeaud A; Toledano H; Bastide C; Lavilledieu S; Avances C; Delage F; Valeri A; Molimard B; Houlgatte A; Gres P; Donnaint A; Kleinclauss F; Legal S; Doerfler A; Koutlidis N; Cormier L; Hetet JF; Colls P; Arvin-Berod A; Rambeaud JJ; Quintens H; Soulie M; Pfister C;
    Ann Surg Oncol; 2014 Feb; 21(2):684-90. PubMed ID: 24170436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
    Chou EC; Lin AT; Chen KK; Chang LS
    Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy.
    Zehnder P; Moltzahn F; Daneshmand S; Leahy M; Cai J; Miranda G; Bartsch G; Mitra AP; Skinner DG; Skinner EC; Gill IS
    BJU Int; 2014 Jan; 113(1):65-9. PubMed ID: 23937628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radical cystectomy in the treatment of cancer of the bladder].
    Herranz Amo F; Díez Cordero JM; Verdú Tartajo F; Bielsa Carrillo A; García Burgos J; Subirá Ríos D; Castaño González I
    Arch Esp Urol; 2000 Sep; 53(7):619-24. PubMed ID: 11037655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].
    Escudero Barrilero A; Fernández Fernández E; Jiménez Cidre M; Maganto Pavón E; Mayayo Dehesa T; Rodríguez Rodríguez R; Galvis San Juan F; Burgos Revilla FJ
    Arch Esp Urol; 1996 May; 49(4):349-64. PubMed ID: 8754191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there an indication for frozen section examination of the ureteral margins during cystectomy for transitional cell carcinoma of the bladder?
    Schumacher MC; Scholz M; Weise ES; Fleischmann A; Thalmann GN; Studer UE
    J Urol; 2006 Dec; 176(6 Pt 1):2409-13; discussion 2413. PubMed ID: 17085117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.